BioMimetic Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 10   

Articles published

BMTI 0.0000
price chart
( PETV ) PetVivo Announces Commercial Launch Schedule
These "made from scratch" biological scaffolds have the hydrophilic biomimetic structure of the body's non-cellular tissue allowing in vivo biochemical interaction, cellular integration, neovascularization, tissue repair, and regeneration as a ...
Related articles »  
Chamber, YP name '14 NELA winners
In her previous role at BioMimetic Therapeutics, Patterson played an integral role in managing the communications, investor, analyst and investment bank relations activity for the company's initial public offering. She is the current president of the ...
Biotech Stock Directory Update
BioMimetic Therapeutics, Inc. (NasdaqGS:BMTI) is a biotechnology company specializing in the development and commercialization of clinically proven products to promote the healing of musculoskeletal injuries and diseases, including therapies for ...
CN Bio Innovations Marks World Hepatitis Day by Signing Research Agreement ...
CN Bio Innovations Ltd (CN Bio) an expert in developing leading edge human biomimetic platforms to test and develop therapeutics for serious diseases announced today that it has signed a research agreement with Imperial College London to advance the ...
Related articles »